Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/UQ1 stock hub

FRA/UQ1 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/UQ1is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

1.5B

Frankfurt Stock Exchange

Market data

Price

Recent price action with selectable time range.

FRA/UQ1FRA/UQ1

—

Loading chart…

In the news

Latest news · FRA/UQ1

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/En/a

P25 n/aP50 n/aP75 n/a

ROE-228.2

P25 n/aP50 n/aP75 n/a

ROIC-164.2

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/UQ1 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

162

Groups with data

Currency

USD

Showing 162 of 162 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Netherlands
Country code	DE
Employees	221
Employees Change	-271%
Employees Change Percent	-56.46
Enterprise value	EUR 1.4B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 1.5B
Price	EUR 21
Price currency	EUR
Rev Per Employee	71,004.79x
Sic	2836
Symbol	fra/UQ1
Website	https://www.uniqure.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.23%
EV Earnings	-7.99x
EV/FCF	-9.67x
EV/Sales	94.1x
FCF yield	-10.1%
P/B ratio	11.44x
P/S ratio	94.4x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -96.3M
Net Income	EUR -181.2M
Pretax Margin	-1,123.34%
Profit Per Employee	EUR -819,693
ROA	-16.41
Roa5y	-6.23
ROCE	-25.26
ROE	-228.2
Roe5y	-96.19
ROIC	-164.2
Roic5y	-48.08

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	7.22%
Cagr1y	97.46%
Cagr3y	3.98%
Cagr5y	-4.77%
Revenue Growth	-10.44x
Revenue Growth Q	127.31x
Revenue Growth3 Y	-45.21x
Revenue Growth5 Y	-13.73x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.03
Assets	EUR 675.4M
Cash	EUR 508.7M
Current Assets	EUR 522.1M
Current Liabilities	EUR 50.2M
Debt	EUR 473.2M
Debt Equity	EUR 3.65
Debt FCF	EUR -3.16
Equity	EUR 129.5M
Interest Coverage	-2.98
Liabilities	EUR 545.8M
Long Term Assets	EUR 153.2M
Long Term Liabilities	EUR 495.6M
Net Cash	EUR 35.5M
Net Cash By Market Cap	EUR 2.39
Net Debt Equity	EUR -0.27
Tangible Book Value	EUR 47.3M
Tangible Book Value Per Share	EUR 0.75

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	10.4
Net Working Capital	EUR -23.4M
Quick ratio	9.97
Working Capital	EUR 482.7M
Working Capital Turnover	EUR 0.03

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-20.23%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	100.84%
1Y total return	97.37%
200-day SMA	21.91
3Y total return	12.42%
50-day SMA	14.26
50-day SMA vs 200-day SMA	50under200
5Y total return	-21.67%
All Time High	74
All Time High Change	-71.62%
All Time High Date	2019-06-18
All Time Low	3.3
All Time Low Change	536.36%
All Time Low Date	2024-07-09
ATR	0.94
Ch YTD	1.74
High	21
High52	60.5
High52 Date	2025-10-30
High52ch	-65.29%
Low	20.25
Low52	7.26
Low52 Date	2026-03-04
Low52ch	189.18%
Ma50ch	47.27%
Price vs 200-day SMA	-4.14%
RSI	72.79
RSI Monthly	52.36
RSI Weekly	52.92
Sharpe ratio	0.97x
Sortino ratio	3.21
Total Return	-20.23%
Tr YTD	1.74
Tr1m	40.94%
Tr1w	30.6%
Tr3m	1.35%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -157.6M
Operating margin	-1,004.4

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	49,862,681%
Shares Insiders	1.46%
Shares Institutions	81.27%
Shares Qo Q	0.6%
Shares Yo Y	20.23%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -165.6M
Average Volume	91x
Bv Per Share	2.05
CAPEX	EUR -392,887
Ch10y	100.8
Ch1m	40.94
Ch1w	30.6
Ch1y	97.37
Ch3m	1.35
Ch3y	12.42
Ch5y	-21.67
Ch6m	-8.7
Change	10.41%
Change From Open	3.7
Close	19.02
Days Gap	6.47
Depreciation Amortization	11,182,922.9
Dollar Volume	2,730
Earnings Date	2026-05-05
EBIT	EUR -157.6M
EBITDA	EUR -146.2M
EPS	EUR -3.02
F Score	2
FCF	EUR -149.7M
FCF EV Yield	-10.35x
Financing CF	290,786,609
Fiscal Year End	December
Founded	1,998
Goodwill	21,038,785.2
Income Tax	EUR 4.9M
Investing CF	-210,890,933
Is Primary Listing	0
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Ma150	23.74
Ma150ch	-11.54%
Ma20	15.71
Ma20ch	33.71%
Net CF	-66,887,043
Next Earnings Date	2026-05-11
Open	20.25
Position In Range	100
Ppne	20,584,277.6
Price Date	2026-05-08
Ptbv Ratio	31.31
Relative Volume	1.43x
Revenue	15,692,059x
SBC By Revenue	101.47x
Share Based Comp	15,922,761
Tax By Revenue	31.08x
Tr6m	-8.7%
Volume	130

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/UQ1 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/UQ1 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/UQ1?

Insider, institutional, and short-interest positioning.

Institutional ownership

+81.3%

Share of float held by funds and institutions

Insider ownership

+1.5%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+20.2%

Negative means the company is buying back shares.

Technical

FRA/UQ1 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

72.8

Above 70: short-term overbought

Price vs 200-day MA

-4.1%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.97

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/UQ1

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/UQ1 stock rating?

fra/UQ1 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/UQ1 analysis?

The full report lives at /stocks/fra/UQ1/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/UQ1?

The latest report frames fra/UQ1 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/UQ1 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.